Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6.41
- Day Range
- $6.97–7.08
- 52-Week Range
- $6.41–8.30
- Bid/Ask
- $6.22 / $106.96
- Shares Outstanding
- 741.67M
- Market Cap
- $5.25B
- Volume/Avg
- 340 / 3,289
Key Statistics
- Price/Earnings (Normalized)
- 9.87
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- 4.69%
- Dividend Yield (Forward)
- 4.69%
- Dividend Payment Schedule
- Feb, Sep
- Total Yield
- 4.69%
Company Profile
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Large Value
- Total Number of Employees
- 49,608
- Website
- https://www.sphchina.com
Valuation
|
Metric
|
SHPMY
|
|---|---|
Price/Earnings (Normalized) | 9.87 |
Price/Book Value | 0.46 |
Price/Sales | 0.13 |
Price/Cash Flow | 3.44 |
Price/Earnings
SHPMY
Financial Strength
|
Metric
|
SHPMY
|
|---|---|
Quick Ratio | 1.02 |
Current Ratio | 1.34 |
Interest Coverage | 6.53 |
Quick Ratio
SHPMY
Profitability
|
Metric
|
SHPMY
|
|---|---|
Return on Assets (Normalized) | 1.41% |
Return on Equity (Normalized) | 4.39% |
Return on Invested Capital (Normalized) | 2.94% |
Return on Assets
SHPMY
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|yX<dCc | LOCK|<MF< | $105B | |||
| Cencora Inc
COR
| LOCK|zw<b%@ | LOCK|nxXl | $59B | |||
| Cardinal Health Inc
CAH
| LOCK|@hh<@$ | LOCK|w@&g | $53B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|$?Bp | $21B | |||
| Henry Schein Inc
HSIC
| LOCK|B@$P%n | LOCK|!@?f! | $9B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|?z | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|<X | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|&^$R$ | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|XM | $4B |
United States